載入...
Coverage Policy Development for Personalized Medicine: Private Payer Perspectives on Developing Policy for the 21-Gene Assay
PURPOSE: Personalized medicine is changing oncology practice and challenging decision making. A key challenge is the limited clinical evidence for many personalized medicine technologies. We describe the strategies private payers employed to develop coverage policy for personalized medicine using th...
Na minha lista:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Clinical Oncology
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2936466/ https://ncbi.nlm.nih.gov/pubmed/21197187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.000075 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|